Impact factor for thrombosis research
WitrynaDr. Jamie O'Sullivan, Ph.D. Royal College of Surgeons in Ireland, Dublin, Ireland. Coagulation and Cancer. All members of the Editorial Board have identified their affiliated institutions or organizations, along with the corresponding country or geographic region. Elsevier remains neutral with regard to any jurisdictional claims. Witryna8 kwi 2024 · The Journal of Thrombosis and Thrombolysis is a long-awaited resource for contemporary cardiologists, hematologists, vascular medicine specialists and clinician …
Impact factor for thrombosis research
Did you know?
WitrynaMorten Mørk, Jan J. Andreasen, Lars H. Rasmussen, Gregory Y.H. Lip, ... Søren R. Kristensen. Pages 141-150. View PDF. Article preview. select article Low-molecular weight heparin or direct oral anticoagulants for the … Witryna4 cze 2024 · In this Perspective, we will review data for coagulation abnormalities that occur in association with COVID-19, and the clinical management questions likely to …
WitrynaThrombosis Research. Supports open access. 10.2 CiteScore. 10.409 Impact Factor. Articles & Issues. About. Publish. Order journal. Menu. Articles & Issues. Latest issue; ... select article Additive effect of factor X on the structure and stability of activated factor VII-induced fibrin clot in hemophilic plasma with inhibitor. WitrynaThrombosis Research Journal Impact Factor 2024 Trends . Impact Factor Trend 2000 - 2024. Impact Factor. The impact factor (IF) or journal impact factor (JIF) of …
Witryna30 maj 2024 · 1.2 Broadening opportunities for the global thrombosis and hemostasis community. As the flagship journal of the ISTH, JTH recorded a 2015 Impact Factor of 5.565, as well as a ninth-place ranking in the Hematology category and sixth-place ranking in the Peripheral Vascular Disease category. Witryna13 kwi 2024 · Venous thromboembolism (VTE) – a cardiovascular condition that occurs when a blood clot forms in a vein – can result in death or severe disability. Those who experience short-term immobility ...
WitrynaThrombosis has ceased publication and is no longer accepting submissions. ... BioMed Research International. Journal metrics. Acceptance rate 24%. Submission to final decision 76 days. ... Impact Factor-APC $925. The Scientific World Journal. Journal metrics. Acceptance rate 21%.
Witryna13 lut 2024 · FV-A2086D presented defects in the APC mechanisms associated with FVa inactivation and FV cofactor activity, similar to FV-W1920R, which were consistent with congenital thrombophilia. Background; Factor (F)V plays pivotal roles in both procoagulant and anticoagulant mechanisms. Genetic mutations, FV-W1920R … crypto real investment trustcrypto reading listWitrynaThrombosis Research is an international journal with a goal of rapid dissemination of new information on thrombosis, hemostasis, and vascular biology to advan… crypto real name apexWitrynaResearch and Practice in Thrombosis and Haemostasis (RPTH) is the Open Access journal of the International Society on Thrombosis and Haemostasis (ISTH), … crypto realms warWitrynaPublication of research which will lead to novel approaches in diagnosis, therapy, prognosis and prevention of thrombotic and hemorrhagic diseases is given high … crypto realityWitrynaImpact Factor: 10.407. Citescore: 10.2. SCIMAGO SJR: 1.678. SCIMAGO H-index: 118. Research Ranking (Medicine) 593. Number of Best scientists*: 288. ... Thrombosis … crypto realms war to phpWitryna1 sty 2005 · Patients with venous thrombosis (VT) commonly have an underlying genetic predisposition. The occurrence of VT is a culmination of environmental and genetic risk factors. 1 Important environmental risk factors are advancing age, male sex and obesity, with “risk periods” of surgery, trauma, cancer, immobilization (including … crypto reality patreon